MDXHEALTH (MDXH) Stock Analyst Ratings
NASDAQ:MDXH - Nasdaq - BE0974461940 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to MDXH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.16. This target is 231.23% above the current price.
MDXH was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MDXH.
In the previous month the buy percentage consensus was at a similar level.
MDXH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-31 | Lake Street | Initiate | Buy |
| 2024-03-07 | BTIG | Maintains | Buy -> Buy |
| 2024-03-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-31 | TD Cowen | Initiate | Outperform |
| 2023-05-16 | BTIG | Maintains | Buy -> Buy |
| 2023-03-24 | William Blair | Initiate | Outperform |
| 2023-03-06 | Piper Sandler | Maintains | Overweight |
| 2022-08-26 | BTIG | Maintains | Buy |
| 2021-11-29 | BTIG | Initiate | Buy |
| 2021-11-29 | Oppenheimer | Initiate | Outperform |
| 2021-11-29 | Piper Sandler | Initiate | Overweight |